Parvin Heidarieh

Parvin Heidarieh

Auto-generated profile, based on publicly available information

Parvin Heidarieh

Department of Bacteriology and Virology, Alborz University of Medical Sciences, Karaj, Iran

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2021 in Journal of Applied Microbiology
Verified
Journal Article
Open access
PDF file
HRHanieh Sadat Riahi
Hanieh Sadat Riahi
PHParvin Heidarieh
Parvin Heidarieh
MFMehdi Fatahi‐Bafghi
Mehdi Fatahi‐Bafghi
The genus Pseudonocardia belongs to a group of actinomycetes, and is a member of the family Pseudonocardiacea. The members of this genus are aerobic, Gram-positive, non-motile bacteria that are commonly found in soil, plant, and environment. Although this genus has a low clinical significance, however it has an important role in biotechnology due to the production of secondary metabolites, some of which have anti-bacterial, anti-fungal, and anti-tumor effects. The use of phenotypic tests such as gelatinase activity, starch hydrolysis, catalase, and oxidase tests, as well as molecular methods, such as polymerase chain reaction (PCR), are necessary for Pseudonocardia identification at the genus and species levels.

1 May 2015 in European Journal of Internal Medicine
Verified
Journal Article
Closed access
Abdolrazagh Hashemi ShahrakiAbdolrazagh Hashemi Shahraki
Abdolrazagh Hashemi Shahraki
PHParvin Heidarieh
Parvin Heidarieh
SBSaeed Zaker Bostanabad
Saeed Zaker Bostanabad
AKAzar Dokht Khosravi
Azar Dokht Khosravi
MHMohammad Hashemzadeh
Mohammad Hashemzadeh
MMMehdi Mirsaeidi
Mehdi Mirsaeidi

7 December 2015 in Scientific Reports
Verified
Journal Article
Open access
Abdolrazagh Hashemi ShahrakiAbdolrazagh Hashemi Shahraki
Abdolrazagh Hashemi Shahraki
PHParvin Heidarieh
Parvin Heidarieh
SBSaeed Zaker Bostanabad
Saeed Zaker Bostanabad
MHMohamad Hashemzadeh
Mohamad Hashemzadeh
MFMohamad Mehdi Feizabadi
Mohamad Mehdi Feizabadi
MMMehdi Mirsaeidi
Mehdi Mirsaeidi
The aim of this multicenter study was to determine the genetic diversity and antibiotic susceptibility of clinically isolated Nocardia species. One hundred twenty-seven patients with nocardiosis were randomly selected from 5 provinces of Iran. Molecular diagnosis of Nocardia species was performed using multilocus sequence analysis of gyrase B of the β subunit of DNA topoisomerase (gyrB) and 16S rRNA and subunit A of SecA preproteintranslocase (secA1). Antimicrobial susceptibility testing was performed following the Clinical and Laboratory Standards Institute recommendations. Thirty-five N. cyriacigeorgica, 30 N. asteroides, 26 N. farcinica, 12 N. otitidiscaviarum, and 10 N. abscessus cultures were studied. All isolates were susceptible to linezolid. All isolates of N. cyriacigeorgica, N. asteroides, N. abscessus and N. otitidiscaviarum were susceptible to trimethoprim-sulfamethoxazole, while 8% of N. farcinica isolates were resistant to this drug. All N. otitidiscaviarum isolates were highly resistant to imipenem, but N. cyriacigeorgica, N. asteroides, N. farcinica and N. abscessus were only moderate resistant. The susceptibility patterns vary with different species of Nocardia. Resistance to trimethoprim-sulfamethoxazole in Iran is low and this drug should be first line therapy, unless drug susceptibility testing shows resistance. Linezolid also covers Nocardia well and could be a second line agent.

29 July 2011 in Japanese Journal of Infectious Diseases
Verified
Journal Article
Closed access
PDF file
HSHasan Shojaei
Hasan Shojaei
PHParvin Heidarieh
Parvin Heidarieh
AHAbodolrazagh Hashemi
Abodolrazagh Hashemi
MFMohamad Mehdi Feizabadi
Mohamad Mehdi Feizabadi
ANAbass Daei Naser
Abass Daei Naser
In developing countries where tuberculosis is still a health challenge, the prevalence of nontuberculous mycobacterial diseases is expected to rise as medical conditions that compromise the immune system become more widespread. In the current study, we aimed to determine the presence and diversity of nontuberculous mycobacteria (NTM) causing infections in Iranian patients. Sixty-seven clinical NTM isolates were identified using conventional and molecular methods, including PCR-restriction fragment length polymorphism analysis (PRA) and 16S rRNA sequencing. Out of 67 patients with confirmed mycobacterial infection, 29 had an associated immunosuppressive syndrome, including 9 who were HIV-infected. Forty-nine NTM isolates were identified using PRA, and the remaining 18 isolates were identified using 16S rRNA sequencing. We obtained the following results: Mycobacterium fortuitum, 30 isolates; M. kansasii, 12 isolates; M. gordonae, 8 isolates; M. porcinum, 3 isolates; M. conceptionense, 3 isolates; M. phlei, 2 isolates; and M. austroafricanum, M. avium, M. elephantis, M. intracellulare, M. lentiflavum, M. monacense, M. parascrofulaceum, and M. thermoresistibile, 1 isolate each; and 1 potentially novel mycobacterial species. With regard to the complexity of identification, it is recommended that laboratory diagnosis of NTM diseases be centralized by strengthening or setting up quality national and regional infrastructure.

1 April 2013 in International Journal of Systematic and Evolutionary Microbiology
Verified
Journal Article
Open access
HSHasan Shojaei
Hasan Shojaei
CDCharles Daley
Charles Daley
ZGZoe Gitti
Zoe Gitti
AHAbodolrazagh Hashemi
Abodolrazagh Hashemi
PHParvin Heidarieh
Parvin Heidarieh
ETEnrico Tortoli
Enrico Tortoli
The isolation and characterization of a novel, rapidly growing, scotochromogenic mycobacterial species is reported. Eight independent strains were isolated from clinical specimens from six different countries of the world, two in Iran, two in Italy and one in each of following countries: Greece, the Netherlands, Sweden and the USA. Interestingly, two of the strains were isolated from cerebrospinal fluid. The strains were characterized by rapid growth and presented orange-pigmented scotochromogenic colonies. DNA-based analysis revealed unique sequences in the four regions investigated: the 16S rRNA gene, the rRNA gene internal transcribed spacer 1 and the genes encoding the 65 kDa heat-shock protein and the beta-subunit of RNA polymerase. The phylogenetic analysis placed the strains among the rapidly growing mycobacteria, being most closely related to Mycobacterium gilvum . The genotypic and phenotypic data both strongly supported the inclusion of the strains investigated here as members of a novel species within the genus Mycobacterium; the name Mycobacterium iranicum sp. nov. is proposed to indicate the isolation in Iran of the first recognized strains. The type strain is M05T ( = DSM 45541T = CCUG 62053T = JCM 17461T).

1 March 2016 in Microbial Drug Resistance
Verified
Journal Article
Closed access
PHParvin Heidarieh
Parvin Heidarieh
MMMehdi Mirsaeidi
Mehdi Mirsaeidi
MHMohamad Hashemzadeh
Mohamad Hashemzadeh
MFMohamad Mehdi Feizabadi
Mohamad Mehdi Feizabadi
SBSaeed Zaker Bostanabad
Saeed Zaker Bostanabad
Abdolrazagh Hashemi ShahrakiAbdolrazagh Hashemi Shahraki
Abdolrazagh Hashemi Shahraki
Many species of nontuberculous mycobacteria (NTM) have long been identified as important causes of human disease, the incidence of which is rising. Several reports have suggested increasing trend of both in vitro and in vivo resistance to available treatment regimes. The aim of this study was to evaluate antibiotic susceptibility of clinically relevant NTM isolates using standard microbroth dilution test. Antimicrobial susceptibility testing was performed following National Committee for Clinical Laboratory Standards methods for NTM isolates, including 85 Mycobacterium fortuitum , 39 Mycobacterium chelonae , and 30 Mycobacterium abscessus subsp. abscessus as rapidly growing mycobacteria and 48 Mycobacterium simiae and 40 Mycobacterium kansasii as slowly growing mycobacteria. All isolates were recovered from various types of clinical samples and identified by multilocus sequence analysis. Trimethoprim–sulfamethoxazole (TMP-SMZ), amikacin, tobramycin, clarithromycin, moxifloxacin, linezolid, and imipenem showed better activity against M. fortuitum rather than meropenem, ciprofloxacin, cefoxitin, and doxycycline. Amikacin was active against 93% of M. abscessus subsp. abscessus. Linezolid, clarithromycin, cefoxitin, ciprofloxacin, imipenem, moxifloxacin, tobramycin, TMP-SMZ, doxycycline, and meropenem showed some activities on M. abscessus subsp. abscessus as well. The majority of M. abscessus subsp. abscessus and M. chelonae strains were multidrug resistant. Among the 40 isolates of M. kansasii , all were susceptible to ethambutol, isoniazid, clarithromycin, moxifloxacin, and linezolid. These isolates were also resistant to doxycycline and 50% were resistant to rifampicin and ciprofloxacin. M. simiae was resistant to clarithromycin, doxycycline, isoniazid, and TMP-SMZ, and the majority of isolates showed high levels of resistance to linezolid, ethambutol, ciprofloxacin, streptomycin, and rifampicin. The majority of M. simiae isolates were multidrug resistant. Our data confirm the need for performing of standard susceptibility testing of any clinically important NTM isolate.